Seminars in Liver Disease

Papers
(The TQCC of Seminars in Liver Disease is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Hepatic Stellate Cell–Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis75
The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis63
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity54
Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review42
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials37
Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment30
Direct or Collateral Liver Damage in SARS-CoV-2–Infected Patients28
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities27
Interleukin-17 in Liver Disease Pathogenesis27
Hepatic Alveolar Echinococcosis27
Cellular Senescence in Liver Disease and Regeneration26
Management of Acute Liver Failure: Update 202222
The Role of Liver Zonation in Physiology, Regeneration, and Disease21
Aging and Chronic Liver Disease20
Simplification of Care for Chronic Hepatitis C Virus Infection20
Molecular Mechanisms of Hepatoblastoma19
Machine Perfusion: Cold versus Warm, versus Neither. Update on Clinical Trials19
Early Diagnosis and Prevention of Infections in Cirrhosis17
Nonalcoholic Fatty Liver Disease: Current Global Burden16
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis15
Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update15
Plasma Exchange in Acute and Acute on Chronic Liver Failure14
Evolution of Liver Transplant Selection Criteria and U.S. Allocation Policy for Patients with Hepatocellular Carcinoma14
Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma14
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives14
Hepatitis C Virus Treatment in Children: A Challenge for Hepatitis C Virus Elimination14
Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury13
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination13
Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)—Multi-Omic and Singulomic Approaches13
Wearables, Physical Activity, and Exercise Testing in Liver Disease12
Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management12
The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone12
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future12
Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review12
Shared Mechanisms between Cardiovascular Disease and NAFLD11
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure11
Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?10
Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers10
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease10
Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy9
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems9
Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review9
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics9
Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases9
Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer9
Nonalcoholic Steatohepatitis Promoting Kinases9
0.033401966094971